Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Schwartz, Gregory G
5851  Ergebnisse:
Personensuche X
?
1

Relating Lipoprotein(a) Concentrations to Cardiovascular Ev..:

Szarek, Michael ; Reijnders, Esther ; Jukema, J. Wouter...
Circulation.  149 (2024)  3 - p. 192-203 , 2024
Link: https://doi.org/10.1161/..
 
?
2

Safety of the PCSK9 inhibitor alirocumab: insights from 47 ..:

Goodman, Shaun G ; Steg, Philippe Gabriel ; Szarek, Michael...
European Heart Journal - Cardiovascular Pharmacotherapy.  , 2024
Link: https://doi.org/10.1093/..
 
?
3

Inclisiran in individuals with diabetes or obesity: Post ho..:

Leiter, Lawrence A. ; Raal, Frederick J. ; Schwartz, Gregory G....
Diabetes, Obesity and Metabolism.  , 2024
Link: https://doi.org/10.1111/..
 
?
4

Estimating potential cardiovascular health benefits of impr..:

Ray, Kausik K. ; Gunn, Laura H. ; Conde, Lorena Garcia...
Atherosclerosis.  391 (2024)  - p. 117472 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Effects of statin therapy on diagnoses of new-onset diabete..:

Reith, Christina ; Preiss, David ; Blackwell, Lisa...
The Lancet Diabetes & Endocrinology.  12 (2024)  5 - p. 306-319 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Alirocumab and cardiovascular outcomes according to sex and..:

Bittner, Vera A. ; Schwartz, Gregory G. ; Bhatt, Deepak L....
Journal of Clinical Lipidology.  , 2024
Link: https://doi.org/10.1016/..
 
?
7

Effect of Lanthanum Carbonate on Serum Phosphate, Oxidative..:

Jovanovich, Anna ; Struemph, Taylor ; You, Zhiying...
Kidney360.  , 2024
Link: https://doi.org/10.34067..
 
?
8

Comparison of change in lipoprotein(a) mass and molar conce..:

Szarek, Michael ; Reijnders, Esther ; Steg, Ph Gabriel...
European Journal of Preventive Cardiology.  , 2024
Link: https://doi.org/10.1093/..
 
?
9

Impact of age on the predictive value of NT-proBNP in patie..:

Savonitto, Stefano ; Morici, Nuccia ; Pancani, Silvia...
Diabetes Research and Clinical Practice.  208 (2024)  - p. 111112 , 2024
Link: https://doi.org/10.1016/..
 
?
10

Inclisiran administration potently and durably lowers LDL-C..:

Wright, R Scott ; Raal, Frederick J ; Koenig, Wolfgang...
Cardiovascular Research.  , 2024
Link: https://doi.org/10.1093/..
 
?
11

Effect of proprotein convertase subtilisin/kexin type 9 inh..:

Mohammadi, Kusha A. ; Brackin, Taylor ; Schwartz, Gregory G....
Cancer Medicine.  12 (2023)  16 - p. 16859-16868 , 2023
Link: https://doi.org/10.1002/..
 
?
12

Long‐Term Efficacy, Safety, and Tolerability of Alirocumab ..:

Goodman, Shaun G. ; Steg, Philippe Gabriel ; Poulouin, Yann...
Journal of the American Heart Association.  12 (2023)  18 - p. , 2023
Link: https://doi.org/10.1161/..
 
?
13

EFFICACY AND SAFETY OF INCLISIRAN BY BASELINE BODY MASS IND..:

Leiter, Lawrence A ; Kallend, David G ; Koenig, Wolfgang...
American Journal of Preventive Cardiology.  13 (2023)  - p. 100403 , 2023
Link: https://doi.org/10.1016/..
 
?
14

Correction: Effect of alirocumab on cataracts in patients w..:

Suc, Gaspard ; Schwartz, Gregory G. ; Goodman, Shaun G....
BMC Ophthalmology.  23 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
15

Efficacy and safety of inclisiran in patients with cerebrov..:

Koenig, Wolfgang ; Ray, Kausik K. ; Landmesser, Ulf...
American Journal of Preventive Cardiology.  14 (2023)  - p. 100503 , 2023
Link: https://doi.org/10.1016/..
 
1-15